• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases
      • All News Releases
      • All Public Company
      • English-only


      • News Releases Overview
      • Multimedia Gallery
      • All Multimedia
      • All Photos
      • All Videos


      • Multimedia Gallery Overview
      • Trending Topics
      • All Trending Topics


  • Business & Money
      • Auto & Transportation
      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation


      • Auto & Transportation Overview
      • Business Technology
      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors


      • Business Technology Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Financial Services & Investing
      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Stock Offering
      • Stock Split
      • Venture Capital


      • Financial Services & Investing Overview
      • General Business
      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News


      • General Business Overview
  • Science & Tech
      • Consumer Technology
      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications


      • Consumer Technology Overview
      • Energy & Natural Resources
      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities


      • Energy & Natural Resources Overview
      • Environ­ment
      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters


      • Environ­ment Overview
      • Heavy Industry & Manufacturing
      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco


      • Heavy Industry & Manufacturing Overview
      • Telecomm­unications
      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications


      • Telecomm­unications Overview
  • Lifestyle & Health
      • Consumer Products & Retail
      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys


      • Consumer Products & Retail Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Health
      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine


      • Health Overview
      • Sports
      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories


      • Sports Overview
      • Travel
      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry


      • Travel Overview
  • Policy & Public Interest
      • Policy & Public Interest
      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy


      • Policy & Public Interest Overview
  • People & Culture
      • People & Culture
      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women


      • People & Culture Overview
      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO

      Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Policy & Public Interest
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • People & Culture
    • People & Culture
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Fukushima Report: 10,000 Excess Cancers Expected In Japan As A Result Of 2011 Reactor Meltdowns, Ongoing Radiation Exposure

Japanese Government Criticized for "Disturbing" Failure to Examine Wider Radiation-Related Diseases.


News provided by

Physicians for Social Responsibility, Washington, D.C.; International Physicians for the Prevention of Nuclear War, Berlin, Germany

Mar 09, 2016, 01:30 ET

Share this article

Share this article


WASHINGTON and BERLIN, March 9, 2016 /PRNewswire-USNewswire/ -- Residents of the Fukushima area and the rest of Japan will experience more than 10,000 excess cancer deaths as a result of radiation exposure from the triple-reactor meltdown that took place on March 11, 2011, according to a new report from Physicians for Social Responsibility (PSR) and International Physicians for the Prevention of Nuclear War (IPPN).

Titled "5 Years Living With Fukushima" and available online at www.psr.org/FukushimaReport2016, the PSR/IPPN report laments that the full impact of Fukushima may never be known, due to Japan's failure to immediately and fully track radiation exposures, as well as a "disturbing" lack of testing of the general population for radiation-related diseases and other impacts (miscarriages, fetal malformations, leukemia, lymphomas, solid tumors or non-cancerous diseases). The massive initial radioactive emissions were not recorded at the time of the triple-reactor meltdown and some radioactive isotopes (including strontium-90) have not been measured at all.

The PSR/IPPNW report uses the best available science and data to gauge the excess cancer rates among children, rescue and clean-up workers, and the general population of Japan. In addition to the 200,000 Fukushima residents relocated nearby into makeshift camps, the exposed include millions of others in Japan as a result of fallout-contaminated food, soil and water. Fukushima is often incorrectly seen as a "past" event; the reality is that radioactive emissions from the wrecked reactors continue to this day both into the atmosphere and in the form of 300 tons of leakage each day into the Pacific Ocean.

 Key findings of the PSR/IPPNW report include the following:

  • Children.  "116 children in Fukushima Prefecture have al­ready been diagnosed with aggressive and fast-growing, or already metastasizing, thyroid cancer – in a population this size about one to five case per year would normally be expected. For 16 of these children a screening effect can be excluded as their cancers developed within the last two years." 
  • Workers.  "More than 25,000 cleanup and rescue workers received the highest radiation dose and risked their health, while preventing a deterioration of the situation at the power plant site. If data supplied by the operator TEPCO is to be believed, around 100 workers are expected to contract cancer due to excess radiation, and 50 percent of these will be fatal. The real dose levels, how­ever, are most likely several times higher, as the operator has had no qualms in manipulating the data to avoid claims for damages – from hiring unregistered temporary employees to tampering with radiation dosimeters and even crude forgery."
  • The rest of Japan.  "The population in the rest of Japan is exposed to increased radiation doses from minor amounts of radioactive fallout, as well as contaminated food and water. Calculations of increased cancer cases overall in Japan range from 9,600 to 66,000 depending on the dose estimates." 

Catherine Thomasson, MD, report co-editor, and executive director, Physicians for Social Responsibility, said: "The health legacy of Fukushima will haunt Japan for years to come and it cannot be wished out of existence by cheerleaders for nuclear power.  Unfortunately, the pro-nuclear Japanese government and the country's influential nuclear lobby are doing everything in their power to play down and conceal the effects of the disaster. The high numbers of thyroid cancers already verified with 50 additional waiting for surgery in the children of Fukushima prefecture is astounding. The aim seems to be to ensure the Fukushima file is closed as soon as possible and the Japanese public returns to a positive view of nuclear power.  This rush to re-embrace nuclear power is dangerous to the extent that it sweeps major and very real medical concerns under the rug."

Dr. Alex Rosen, pediatrician and vice-chair, International Physicians for Prevention of Nuclear War, said: "One is of course reminded of the tobacco lobby disputing the notion that the horrific effects of its products have no adverse health impacts.  This self-serving falsehood echoed for decades was made possible simply because the long-term health effects of smoking were not immediately observable.  The 10,000 to 66,000 people who will develop cancer solely as a result of the "manmade disaster" are neither 'negligible' nor 'insufficient,' as Japanese authorities, the nation's nuclear lobby, and various industry-dominated international bodies, would have you believe."

Tim Mousseau, PhD, professor of Biological Sciences, University of South Carolina, said: "It is unfortunate that, in some regards, we have better and more complete data about the impacts of Fukushima radiation on trees, plants and animals than we do on humans.  We are seeing higher mortality rates, reduction in successful reproduction and significant deformities. A great deal of this research has been done to date and it has troubling implications.   The research findings should be heeded to direct human studies, particularly regarding the question of genetic and transgenerational effects of radiation."

Robert Alvarez, senior scholar specializing in nuclear disarmament, environmental, and energy policies, Institute for Public Studies, and former senior policy advisor, US Department of Energy, said:  "Radioactive fallout from the reactors has created de faco 'sacrifice zones' where human habitation will no longer be possible well into the future. In November 2011, the Japanese Science Ministry reported that long-lived radioactive cesium had contaminated 11,580 square miles (30,000 sq km) of the land surface of Japan. Some 4,500 square miles – an area almost the size of Connecticut – was found to have radiation levels that exceeded Japan's allowable exposure rate of 1 mSV(millisievert) per year. Fourteen of the nation's 54 reactors are permanently shut down as they are on fault lines and only four have been restarted."

SOURCE Physicians for Social Responsibility, Washington, D.C.; International Physicians for the Prevention of Nuclear War, Berlin, Germany

Modal title

    Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

    Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

    About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement

    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom

    My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision


Products


About


My Services
  • All News Releases
  • Online Member Center
  • ProfNet℠
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2021 Cision US Inc.